Medical Imaging Reagents Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2488

The Business Research Company offers in-depth market insights through Medical Imaging Reagents Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The medical imaging reagents market size has grown strongly in recent years. It will grow from $14.06 billion in 2023 to $15.13 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of diseases, growing aging population, expanding applications, regulatory approvals, strategic collaborations and partnerships.

The medical imaging reagents market size is expected to see strong growth in the next few years. It will grow to $19.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to personalized medicine, increasing focus on early disease detection, rising global burden of chronic diseases, expanding point-of-care imaging, integration of theranostics. Major trends in the forecast period include technological advancements, increasing prevalence of chronic diseases, diagnostic imaging in personalized medicine, emerging markets and global expansion, partnerships and collaborations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9917&type=smp

Market Segmentation:
The medical imaging reagents market covered in this report is segmented -

1) By Class: Contrast Reagents, Optical Reagents, Nuclear Reagents
2) By Technology: Nanoparticles, Fluorescent Dyes, Probes Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots
3) By Modality: X-ray, CT Scan, Ultrasound, MRI Scan
4) By Application: Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Other Applications
5) By End User: Biotechnology Companies, Pharmaceutical Companies, Diagnostic Labs

Major Driver - Rising Prevalence Of Chronic Diseases Fuels Surge In The Medical Imaging Reagents Market
The increase in the prevalence of chronic diseases is expected to propel the growth of the medical imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require medical imaging reagents to diagnose and detect diseases by visualizing organs and affected structures. For instance, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Furthermore, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. The increase in the prevalence of chronic diseases is driving the growth of the medical imaging reagents market.

Competitive Landscape:
Major companies operating in the medical imaging reagents market report are General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires André Guerbet, Li-cor Biosciences Inc., Canon Medical Systems Corporation, Fujifilm Healthcare, Aidoc Medical, Guerbet Group, Lantheus Medical Imaging Inc., Merck KGaA, Beckman Coulter Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Rotem Industries Ltd., JFE Engineering Corporation, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/medical-imaging-reagents-global-market-report

Top Trend - Innovative Instruments Driving Progress In The Medical Imaging Reagents Market
Product innovations are a key trend gaining popularity in the medical imaging reagents market. Major companies operating in the medical imaging reagents market are focused on developing new solutions to sustain their position in the market. For instance, in March 2023, Aptamer Group plc, a UK-based company that manufactures medical imaging reagents launched Optimer-Fc. It is made up of an Optimer binder coupled to an antibody's Fc domain, which enables a wide range of Optimer instruments to be used in IHC applications. Optimer-Fc is an antibody substitute for primary detecting antibody that can be used in current workflows. IHC is used to identify disease markers, such as cancer, in cells. With the creation of a new reagent suite to facilitate enhanced research, diagnostics, and forensics, as well as enhanced precision and selectivity in detection, this development in opter binders will allow life scientists to explore both new and established disease biomarkers.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Medical Imaging Reagents Market Characteristics
3. Medical Imaging Reagents Market Trends And Strategies
4. Medical Imaging Reagents Market - Macro Economic Scenario
5. Medical Imaging Reagents Market Size And Growth
…..
27. Medical Imaging Reagents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.